United Therapeutics Insider Sold Shares Worth $5,215,015, According to a Recent SEC Filing
MT newswire2026/10/08 21:3305:33 PM EDT, 10/08/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on October 07, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,215,015. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000159/xslF345X05/primarydocument.xml
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Today's Fear and Greed Index drops to 59, indicating the market is in a "Greed" state.
The global PC market faces a "winter"! Q3 shipments plunged by over 20%, Apple (AAPL.US) gains market share against the trend
Due to supply constraints and inventory pre-stocking impacting sales, the personal computer (PC) market plummeted by over 20% year-on-year in the third quarter. Despite the overall market downturn, Apple outperformed the industry and achieved a gain in market share.
Polymarket has started charging fees for geopolitical events.
SpaceX shareholders gamble with creditors' money amid split between stocks and bonds
Crypto prices
More
